Why Does HPV Increase the Risk of Oropharyngeal Cancer? Carcinogenic Mechanisms, Diagnosis, and the Latest Treatment Advances

Learn how persistent HPV infection causes oropharyngeal cancer, the roles of E6/E7 proteins, current diagnostic methods, and the latest advances in immunotherapy and ADCs.

Top Stories

38 Innovative Drugs Approved in China in the First Half of 2026

Can TCR-T Become the Next Breakthrough for Advanced Head and Neck Cancer?

Latest Coverage

ADC Landscape in Head and Neck Cancer: Latest Advances in HER3, EGFR, B7-H3, and Other Emerging Targets
In recent years, antibody-drug conjugates (ADCs) have become one of the fastest-growing areas of innovation in oncolo...

Why Do Many Solid Tumor Treatments Still Rely on Infusion Therapy? The 2026 Landscape of Oncology Injection-Based Treatments
Over the past decade, oncology treatment has undergone a significant transition toward de-chemotherapy and oral targe...

From Liposomes to ADCs: Breakthroughs of Novel Drug Delivery Systems in Cancer Therapy
In recent years, cancer treatment has gradually shifted from the era of “broad-spectrum cytotoxicity” toward the era ...

How Is a Pituitary Tumor Treated? A Comprehensive Guide to Surgery, Medication, and Radiation Therapy
Discover the latest treatment options for pituitary tumors, including dopamine agonists, endoscopic transsphenoidal s...

CAR-T Therapy for Head and Neck Cancer: Challenges, Clinical Progress, and Future Perspectives
Learn why CAR-T therapy has revolutionized blood cancer treatment but remains challenging for head and neck cancer. E...

What Is the Survival Rate of Medulloblastoma? Key Factors Affecting Prognosis
Discover how molecular classification, surgery, radiotherapy, chemotherapy, and multidisciplinary care influence surv...

In-Depth Analysis

Why Does HPV Increase the Risk of Oropharyngeal Cancer? Carcinogenic Mechanisms, Diagnosis, and the Latest Treatment Advances

38 Innovative Drugs Approved in China in the First Half of 2026

Can TCR-T Become the Next Breakthrough for Advanced Head and Neck Cancer?

ADC Landscape in Head and Neck Cancer: Latest Advances in HER3, EGFR, B7-H3, and Other Emerging Targets